Literature DB >> 8472364

Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry.

B A Goldberger1, W D Darwin, T M Grant, A C Allen, Y H Caplan, E J Cone.   

Abstract

A solid-phase extraction procedure was developed for the isolation of heroin, 6-acetylmorphine, and morphine from blood, plasma, saliva, and urine with subsequent assay by gas chromatography/mass spectrometry. Aprotic solvents, mild elution conditions, and an enzyme inhibitor were used to ensure maximum analyte stability. Samples were extracted and the extract was divided into two equal portions. One portion was assayed directly for heroin; detector response was linear over a concentration range of 1.0 to 250 micrograms/L. The second part of the extract was reacted with N-methyl-bis-trifluoroacetamide and assayed for the trifluoroacetyl derivatives of 6-acetylmorphine and morphine; detector response was linear over a concentration range of 1.0 to 500 micrograms/L. The limit of sensitivity was 1.0 microgram/L for each analyte. Hydrolysis of heroin to 6-acetylmorphine during extraction and analysis was < 5%. The method can be used to corroborate heroin use and to study the pharmacological effects of heroin and its metabolites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472364

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.

Authors:  Riet Dams; Robin E Choo; Willy E Lambert; Hendree Jones; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2006-09-27       Impact factor: 4.492

2.  Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat.

Authors:  Bertrand R Brunet; Allan J Barnes; Karl B Scheidweiler; Patrick Mura; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2008-07-08       Impact factor: 4.142

3.  Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital.

Authors:  Jessica L Moreno; Matthew S Duprey; Bryan D Hayes; Kirsten Brooks; Sabrina Khalil; Sarah E Wakeman; Russell J Roberts; Jared S Jacobson; John W Devlin
Journal:  Toxicol Commun       Date:  2019-12-09

4.  Determining plasma morphine levels using GC-MS after solid phase extraction to monitor drug levels in the postoperative period.

Authors:  Veronica Santos; Karin Jannet Vera López; Luciana Moraes Santos; Mauricio Yonamine; Maria José Carvalho Carmona; Silvia Regina Cavani Jorge Santos
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

5.  Identifying cases of heroin toxicity where 6-acetylmorphine (6-AM) is not detected by toxicological analyses.

Authors:  Ashley D Ellis; Gerald McGwin; Gregory G Davis; Daniel W Dye
Journal:  Forensic Sci Med Pathol       Date:  2016-04-25       Impact factor: 2.007

6.  Chemiluminescence based immunoassay for the detection of heroin and its metabolites.

Authors:  Smritee Singh; Priya Mishra; Ivneet Banga; Avanish S Parmar; Prem Prakash Tripathi; Sonu Gandhi
Journal:  Bioimpacts       Date:  2017-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.